Fig. 3. No significant differences in primary or secondary outcomes were observed between the two groups. Mean Sequential Organ Failure Assessment scores were 7.9 and 8.3 in the meropenem and the moxifloxacin plus meropenem groups, respectively. Mortality and infection rates were similar (A ) and days spent in the intensive care unit (ICU) or intervention-free were similar (B ). RRT = renal replacement therapy.